help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-1348
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dagogo-Jack, S.
Right arrow Articles by Tykodi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dagogo-Jack, S.
Right arrow Articles by Tykodi, G.
Related Collections
Right arrow Diabetes and Insulin
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 6 2031-2036
Copyright © 2009 by The Endocrine Society

Glucoregulatory Physiology in Subjects with Low-Normal, High-Normal, or Impaired Fasting Glucose

Samuel Dagogo-Jack, Hasan Askari and Gunjan Tykodi

Division of Endocrinology, Diabetes, and Metabolism (S.D.-J.), University of Tennessee Health Science Center, Memphis, Tennessee 38163; and Division of Endocrinology, Diabetes, and Metabolism (H.A., G.T.), Washington University School of Medicine, St. Louis, Missouri 63110

Address all correspondence and requests for reprints to: Samuel Dagogo-Jack, M.D., University of Tennessee Health Science Center, 920 Madison Avenue, Suite 300A, Memphis, Tennessee 38163. E-mail: sdj{at}utmem.edu.

Objective: We determined whether variations in fasting plasma glucose (FPG) within the nondiabetic range represent differences in insulin action or secretion.

Subjects and Methods: Using results of the 75-g oral glucose tolerance test, we classified 39 adults (body mass index range 20–56 kg/m2) as having normal fasting glucose (NFG, <100 mg/dl, n = 24) or impaired fasting glucose (IFG, 100–125 mg/dl, n = 15). The NFG group was subdivided into low-NFG (<90 mg/dl, n = 11) and high-NFG (90–99 mg/dl, n = 13). The 2-h oral glucose tolerance test plasma glucose value was used to assign normal or impaired glucose tolerance (IGT) status. Insulin sensitivity was assessed by hyperinsulinemic euglycemic clamp, quantitative insulin sensitivity check index, and homeostasis model assessment of insulin resistance; β-cell function was assessed by calculating the insulinogenic index, homeostasis model assessment, and the disposition index.

Results: Compared with low-NFG subjects, insulin sensitivity and glucose tolerance were lower among persons with isolated IFG and combined IFG-IGT. The hyperinsulinemic euglycemic clamp (µmol/kg · min–1/pmol/liter) was 0.109 ± 0.011 in low-NFG subjects, 0.088 ± 0.009 in IFG subjects (P = 0.04), and 0.022 ± 0.003 in IFG-IGT subjects (P = 0.0014). The spread in FPG from 70–125 mg/dl was associated with a greater than 3-fold difference in insulin sensitivity. Compared with low-NFG subjects, the disposition index decreased by 32.8% in high-NFG subjects (P = 0.08), by 45.6% in subjects with isolated IFG (P < 0.02), and by 49.8% (P < 0.02) in those with combined IFG-IGT.

Conclusion: Compared with persons with low-NFG, those with IFG or combined IFG-IGT have significant alteration of glucoregulatory physiology, whereas high-NFG (pre-prediabetes) status might portend nascent glucoregulatory perturbations.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society